Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 16S ribosomal RNA (rRNA) is a component of the small (30S) subunit of prokaryotic ribosomes and plays a critical role in protein synthesis. It contains both highly conserved and hypervariable regions, making it a valuable phylogenetic marker for bacterial identification and taxonomic classification. The 16S rRNA gene is widely used in clinical diagnostics to detect and identify bacterial pathogens, even in cases where traditional culture methods are ineffective. While not a direct therapeutic target, its essential role in bacterial protein synthesis makes it an indirect target for many antibiotics.
Inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby interfering with tRNA binding, mRNA decoding, or translocation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 16S ribosomal RNA.